About Atlantis Mayaguez Mc
Address: 1St Floor Office Park Iv Building, Mayaguez, Mayaguez County, PR, 681Phone Number: (787) 292-7979
Certification Date: June 25, 2002
Type and Organization: Profit, Atlantis Healthcare Group
Number of Dialysis Stations: 18
Atlantis Mayaguez Mc Location on Map
Service Offers and Quality Reviews
- In-Center Hemodialysis (YES)
- In-Center Peritoneal Dialysis (YES)
- Home Hemodialysis Training (NO)
- SHR: Upper Confidence Limit (95%): 1.69
- SMR: Upper Confidence Limit (95%): 1.56
- SHR: Lower Confidence Limit (5%): 0.58
- SMR: Lower Confidence Limit (5%): 1.03
- Number of patients included in hospitalization summary: 83
- Number of patients included in survival summary: 589
- Standardized hospitalization ratio: 0.99
- Standardized mortality ratio: 1.27
- Percentage of Medicare patients with Hgb< 10 g/dL: 0.03
- Percentage of Medicare patients with Hgb>12 g/dL: 0
- Number of dialysis patients with Hgb data: 30
- Percentage of HD patients with URR>=65%: 1
- Percent of Adult HD patients with Kt/V >= 1.2: 0.97
- Percentage of Adult PD PTS with Kt/V >= 1.7: n/a
- Number of HD patients with URR data: 25
- Number of Adult HD patients with Kt/V data: 37
- Number of Adult HD patient-months with Kt/V data: 291
- Number of Adult PD patients with Kt/V data: 9
- Number of Adult PD patient-months with Kt/V data: 77
- Number of Pediatric HD patients with Kt/V data: 0
- Number of Pediatric HD patient-months with Kt/V data: 0
- Percentage of patients with arteriovenous fistulae in place: 0.46
- Percentage of patients with vascular catheter in use for 90 days or longer: 0.08
- Number of Adult patients included in arterial venous fistula and catheter summaries: 40
- Number of Adult patient-months included in arterial venous fistula and catheter summaries: 297
(Claims Date: 07/01/2011-06/30/2012; SMR Date: 01/01/2008-12/31/2011; SHR Date: 01/01/2011-12/31/2011)
n/a = Data note available or the number of patients is too small to report, please contacts the dialysis facility to discuss this quality measure.
No comments:
Post a Comment